ahlam1399
09-09-2015, 01:08 AM
UPDATE 1-Glaxo, Theravance Breo lung drug fails to extend life in huge study
Sept 8 (Reuters) - GlaxoSmithKline Plc and its partner Theravance Inc on Tuesday said their inhaled medicine Breo failed to prolong life of patients with chronic respiratory disease in a huge, high-stakes clinical trial.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49aced6a/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=YWE7UuTi5uk:J1rfYR37ZTQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=YWE7UuTi5uk:J1rfYR37ZTQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=YWE7UuTi5uk:J1rfYR37ZTQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=YWE7UuTi5uk:J1rfYR37ZTQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=YWE7UuTi5uk:J1rfYR37ZTQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/YWE7UuTi5uk
Sept 8 (Reuters) - GlaxoSmithKline Plc and its partner Theravance Inc on Tuesday said their inhaled medicine Breo failed to prolong life of patients with chronic respiratory disease in a huge, high-stakes clinical trial.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49aced6a/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=YWE7UuTi5uk:J1rfYR37ZTQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=YWE7UuTi5uk:J1rfYR37ZTQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=YWE7UuTi5uk:J1rfYR37ZTQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=YWE7UuTi5uk:J1rfYR37ZTQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=YWE7UuTi5uk:J1rfYR37ZTQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/YWE7UuTi5uk